Our experience in biologics and biosimilars can help you navigate your brand through this changing landscape.
The biologics market is evolving at a rapid pace.
Once considered blockbuster therapies, loss of patent exclusivity has opened up biologics to new competition from cheaper biosimilar versions. Biosimilars have in turn gained increased market acceptance, but breaking into established areas does not come without its challenges. To round off, the latest generation of bio-betters in development are set to change the future landscape for both originator biologics and biosimilars even further.
Our team of researchers has a wealth of experience in helping marketers to navigate through this changing landscape and develop highly competitive brand strategies, whatever the challenge they face.
To develop robust access strategies
Communication and message testing
To unlock competitive campaigns
Understand how to drive adoption
Trial, usage and awareness research
Track brand health amidst key market changes
To establish the best approach for competitive edge
Some research approaches we’ve utilised include:
To unearth new drivers to leverage against the competition.